Literature DB >> 19022680

Recurrent ameloblastoma following osseous reconstruction--a review of twenty years.

André M Eckardt1, Horst Kokemüller, Peter Flemming, Arndt Schultze.   

Abstract

BACKGROUND: The adequate therapy of ameloblastoma may require a compromise between the least destructive treatment possible of a benign tumour and a sufficiently radical method to prevent recurrences. Frequently recurrences appear after 10 years or longer, therefore regular follow-up visits even after more than 5 years are recommended. The primary reconstruction of bones and/or soft tissues, which is likely to be performed especially for benign processes is threatened by recurrences.
METHODS: A retrospective analysis of our patient group during the past 20 years has shown that a differentiated pretherapeutic securing of the histology as well as a radical surgical policy are the most important criteria, influencing the likelihood of recurrences. Three representative case histories are described below.
RESULTS: The rate of cumulative relapses with regard to various observation time amounted to 17% after 5 years and 19% after 10 years, respectively.
CONCLUSION: Ameloblastomas carry a certain risk of developing local recurrences depending on histology and the type of surgical treatment. Long-term follow-up should be arranged.

Entities:  

Mesh:

Year:  2008        PMID: 19022680     DOI: 10.1016/j.jcms.2008.07.009

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  11 in total

1.  Difficulties in the diagnosis of plexiform ameloblastoma.

Authors:  Igor Iuco Castro-Silva; Monica Simoes Israel; Glauco Siqueira Lima; Simone de Queiroz Chaves Lourenço
Journal:  Oral Maxillofac Surg       Date:  2011-03-01

2.  [Maxillary ameloblastoma extending into the sinonasal tract].

Authors:  H Geddert; S Runge; U Werner; H Walendzik; A Dimmler
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

Review 3.  Ameloblastoma: a clinical review and trends in management.

Authors:  Andrew C McClary; Robert B West; Ashley C McClary; Jonathan R Pollack; Nancy J Fischbein; Christopher F Holsinger; John Sunwoo; A Dimitrios Colevas; Davud Sirjani
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-30       Impact factor: 2.503

4.  Recurrent unicystic ameloblastoma in a child.

Authors:  Irulandy Ponniah
Journal:  J Oral Maxillofac Pathol       Date:  2011-05

5.  Soft tissue recurrent ameloblastomas also show some malignant features: A clinicopathological study of a 15-year database.

Authors:  Zitong Lin; Guowen Sun; Tiemei Wang; Qingang Hu; Fei Chen; Shanhui Wen
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-05-01

6.  Recurrent Ameloblastoma: A Surgical Challenge.

Authors:  Chithra Aramanadka; Abhay Taranath Kamath; Adarsh Kudva
Journal:  Case Rep Dent       Date:  2018-02-21

7.  Ameloblastoma: clinical presentation, multidisciplinary management and outcome.

Authors:  Abelardo Medina; Ignacio Velasco Martinez; Benjamin McIntyre; Ravi Chandran
Journal:  Case Reports Plast Surg Hand Surg       Date:  2021-02-22

8.  Ameloblastoma Management: "Horses for Courses" Protocol.

Authors:  Suresh Menon; Veerendra Kumar; S Archana; Priyangana Nath; Satyapriya Shivakotee; Mahbubul Hoda
Journal:  J Maxillofac Oral Surg       Date:  2019-01-23

9.  Treatment of recurrent mandibular ameloblastoma.

Authors:  Pedro Infante-Cossio; Victoria Prats-Golczer; Luis-Miguel Gonzalez-Perez; Rodolfo Belmonte-Caro; Rafael Martinez-DE-Fuentes; Eusebio Torres-Carranza; Purificacion Gacto-Sanchez; Tomas Gomez-Cia
Journal:  Exp Ther Med       Date:  2013-06-18       Impact factor: 2.447

10.  Recurrent Ameloblastoma Involving Fibula Neo-mandible: Management with Digital Planning and Reconstruction Using a Contralateral Free Fibula Flap.

Authors:  Suzanne M Beecher; Paul Lennon; Michael O'Shaughnessy; Conor P Barry
Journal:  Cureus       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.